
Conference Coverage
12 days ago
How Do GLP-1 Agonists Fit Into Stroke Care?Latest Content

Abortion Clinics Are Shuttering Even in Major Access States

New Pediatric Soft Tissue Sarcoma Guidelines Emphasize Risk Stratification, Clinical Trials

Blood Pressure Therapy Intensity Correlates With Cardiac Function in ACDHF

Unprecedented Spike in Plan Exits Threatens Medicare Advantage Stability

FDA Reverses Course, Will Review Moderna’s mRNA Flu Vaccine

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

Learn what sickle cell disease is, who it affects most, today’s treatment options, and how cost and inequities limit access.

Systematic review finds sleep disturbances in menopause are highly prevalent and linked to worse QOL, depression, pain, and reduced work productivity.

A new Mayo Clinic study questions the benefit of implantable cardioverter-defibrillator use to treat patients with transthyretin cardiac amyloidosis.

A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions.

Patients with myasthenia gravis (MG) had greater morbidity and extended hospitalization when they underwent cardiac surgery.

Advances in sickle cell therapies, including gene editing, offer hope—but racial disparities, cost, and access barriers remain major challenges.

Today's approval enables once-monthly SC amivantamab dosing for patients with EGFR-mutant NSCLC, reducing clinic visits without compromising efficacy or safety.

Experts at a roundtable in Boston, Massachusetts, on November 19, 2025, discussed multidisciplinary strategies for obesity care, including systemic and operational barriers and scalable solutions to promote patient ownership.

New bipartisan legislation extends key health care programs and tightens oversight of PBMs in Medicare Part D and commercial markets, but impacts on drug costs will not be immediate.

Penetration of Medicare Shared Savings Program accountable care organizations and Medicare Advantage was not associated with substantive changes in health care use among commercial enrollees.






























